Showing results (1-10 of 148) with videos related to

Sort By:
Pageof 15
Chest|May 1, 1996
Quality of life as a new end pointP Kosmidis
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 1, 1988
Reduction of oral toxicity of 5-fluorouracil by allopurinol mouthwashesN Tsavaris, P Caragiauris, P Kosmidis
Cancer Immunology, Immunotherapy : CII|October 1, 1996
The prognostic significance of immune changes in patients with renal cancer, melanoma and colorectal cancer, treated with interferon alpha 2bN Tsavaris, C Baxevanis, P Kosmidis, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1995
The prognostic significance of immune changes in patients with renal cancer and melanoma treated with interferon-alpha 2bN Tsavaris, K Baxevanis, P Kosmidis, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|May 1, 1995
Combined transarterial targeting locoregional immunotherapy-chemotherapy for patients with unresectable hepatocellular carcinoma: a new alternative for an old problemN J Lygidakis, P Kosmidis, N Ziras, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 10, 2010
EGFR gene copy number as a predictive biomarker for patients receiving tyrosine kinase inhibitor treatment: a systematic review and meta-analysis in non-small-cell lung cancerI J Dahabreh, H Linardou, P Kosmidis, et al.
British Journal of Cancer|March 30, 2006
Epoetin alfa in platinum-treated ovarian cancer patients: results of a multinational, multicentre, randomised trialP M Wilkinson, M Antonopoulos, M Lahousen, et al.
Pageof 15